Navigation Links
Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
Date:9/20/2007

MEDIA, Pa., Sept. 20 /PRNewswire-FirstCall/ -- Synova Healthcare Group, Inc. (OTC Bulletin Board: SNVH), today announced that it completed the sale of approximately $3.3 million in aggregate notional principal amount of its 6.5% senior convertible promissory notes, Series B, due September 19, 2012, and related common stock purchase warrants. This sale was effected as the initial part of an ongoing private placement of notes and warrants in the aggregate notional principal amount of up to $5 million. The notes were sold to certain accredited investors and foreign investors.

The notes mature on September 19, 2012 and are convertible into shares of Synova common stock at a conversion rate of one share for every $1.00 of principal and accrued and unpaid interest converted, subject to anti-dilution adjustments for certain corporate transactions. Synova's obligations under the notes are unsecured.

As part of this offering, Synova issued a warrant to each purchaser of the notes. The warrants have a term of five years and are exercisable for shares of Synova common stock at a price of $1.00 per share, subject to anti-dilution adjustments for certain corporate transactions. Each warrant entitles the holder to acquire a number of shares of Synova common stock equal to 180% of the number of shares that such holder could acquire upon conversion of such holder's notes. Synova will use the net proceeds received from this offering to provide continued investment in the Today(R) Sponge, to further expand its growing portfolio of women's health care products, and for general corporate purposes.

The offer and sale of these notes required the consent of the holders of Synova's existing 6.5% senior convertible promissory notes due January 12, 2012. As consideration for these consents and certain other waivers of, and amendments to, various agreements related to the January notes, Synova and its subsidiaries agreed to grant to the holders of the January notes a
'/>"/>

SOURCE Synova Healthcare Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
2. iGATE Completes Phase I Testing Of Meningitis Vaccine
3. Delhi Hospital Completes 100 Liver Transplants
4. Roche Completes Acquisition of BioVeris
5. Drug May Make Breathing Easier for Millions
6. Hundred million dollar gift for malaria institute
7. George Bush pledges 200 million dollars for AIDS relief
8. Hope for 11 million children facing death from illnesses
9. The forgotten epidemic killing millions
10. WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005
11. Over Six Million HIV Infected People In South Africa- Finds A Survey

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... , Moravia,s Nanjing-base...in Jiangsu Province , Brn...leading globalization solution provider, is please...a Business Summit 2009, to be held in Nanjing, Chi... of the European Union-based companies that have e...
(Date:11/29/2009)... , The Academy of General...of Orange county CA, received the Mastership Award...cognizes AGD members, commitment to excellence in ...completed 1,100 hours of approved continuing denta...cluding 400 hours dedicated to hands-on skills and...
(Date:11/29/2009)... , SANTA CRUZ, CA--New connections begin to for...s learn a new task, according to a study published...University of California, Santa Cruz, the study in...sses that take place in the brain during motor lea...re trained to reach through a slot to get a seed. ...
(Date:11/29/2009)... Witnessing someone get blamed for something lead...nds , , SUNDAY, Nov. 29 (HealthDay News)...y reports, even when the target is innocent. , ...me someone else for a problem, even if it,s an unf... in blaming others, too. , "When we see others...
(Date:11/29/2009)... Many doctors unaware the sleep disorder boosts u..., Nov. 29 (HealthDay News) -- People who wake up d... blame a urological problem. Sleep apnea, a breath..., A new study suggests that nighttime urination, ...rker for obstructive sleep apnea, a disorder in wh...
Breaking Medicine News(10 mins):Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:When Accusations Start to Fly, They Multiply 2Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3
...,President and CEO of Varian, Inc. (NasdaqGS: VARI...e Conference in San Francisco on Monday, January,7...cast of the presentation will be publicly availabl...ailable to the public from Varian, Inc.,s Web site...
... way of saying, ,Help!, , , THURSDAY, Dec...ghing or have a cough that lasts for weeks, you ma... medical attention. , "Cough is the most common r...logy,s cough committee, said in a prepared stateme...
...lves in New Year, VAN NUYS, Calif., Dec. 27 Appr...ve cervical cancer/HPV this year,and nearly 4,000 ...s,January, during Cervical Health Awareness Month,...cer/HPV and about,vaccines that can further reduce...
... University of Minnesota Center for Drug Design a...discovered a new fast-acting antidote to cyanide p... of those who are exposed to the chemical namely ... a certain point, said Steven Patterson, Ph.D., pr...
...ing with,every play of your favorite team or it,s ... game watching experience, being a die-hard footba... the number one selling OTC,heartburn medicine bas... at:, http://media.medialink.com/WebNR.aspx?story=...
... research to needle exchanges to medical marijuana...he way of science, according to a new book by a le...health issues at Weill Cornell Medical College. , ...essor of clinical public health, director of the O...
Other Medicine News:Health News:National Cervical Cancer Coalition Stresses Importance of Screening and Prevention During January Cervical Health Awareness Month 2Health News:U of M researchers discover fast-acting cyanide antidote 2
(Date:11/29/2009)... FUJIFILM Medical Systems USA, Inc. is pleased to ...l DR cassette, at the 2009 Radiological Society of...ny clinical environment, FDR D-EVO uses an innovat...film,s trademark image quality and outstanding fle...o transition to DR without modification to the exa...
(Date:11/28/2009)...-- Siemens Healthcare redefines productivity with...g matrix) technology and with its new Dot(TM) (Day...are introduced in the new MAGNETOM ® Aera* 1...rs at the 95th Scientific Assembly and Annual Meet...RSNA) from November 29 to December 3 at McCormick ...
(Date:11/26/2009)...Nov. 26 The 2009 Frost & Sulli...Generic Pharmaceutical Market is presented to Cipl...//www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,...ing criteria were used to benchmark Cipla Medpro,s...egy and implementation, degree of innovation in bu...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 1Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 2Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 3Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 4High Cholesterol in Midlife Raises Risk of Late Life Dementia Kaiser Permanente Study Finds 53582 1High Cholesterol in Midlife Raises Risk of Late Life Dementia Kaiser Permanente Study Finds 53582 2High Cholesterol in Midlife Raises Risk of Late Life Dementia Kaiser Permanente Study Finds 53582 3High Cholesterol in Midlife Raises Risk of Late Life Dementia Kaiser Permanente Study Finds 53582 4Hip and back fractures increase mortality rates in people older than 50 53579 1Hip and back fractures increase mortality rates in people older than 50 53579 2
...ngle, Higher, More Concentrated Dose of ...f., Aug. 22 Nuvelo, Inc.,(Nasdaq: NUVO ) today a...NOMA-3 (Speedy Opening of Non-functional and Occlu...evaluating lead product candidate,alfimeprase, for...n (CO). This open-label, single-arm trial will ev...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced t...ial update session on anti-arrhythmia data from th...sentation at the European Society,of Cardiology (E...from,September 1-5, 2007. A clinical trial update...el Anti-anginal Agent with Electrophysiologic Prop...
Other Medicine Technology:Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion 2Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion 3Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion 4CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 3
Wright stain
Albumin Reagent Set
AST (SGOT) Reagent Set (UV-Kinetic Method)
AST GOT Reagent
Medicine Products: